Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma
- PMID: 21253477
- PMCID: PMC3022193
- DOI: 10.1155/2010/250606
Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma
Abstract
Context. Immunohistochemical stains for p53 are used as a diagnostic marker associated with malignancy in several histologic types of salivary gland tumors. This marker may be useful in differentiating pleomorphic adenoma (PA) from carcinoma ex pleomorphic adenoma (CPA), as these tumors are often difficult to distinguish on the basis of morphology alone. Objective. to evaluate whatever inactivation of tumor suppressor gene (p53) increases with the tumor progression from normal salivary tissue to PA and eventually CPA. Design. Paraffin blocks of 29 cases of PA, which were surrounded by normal parotid gland, and 27 cases of carcinoma ex pleomorphic adenoma were retrieved and validated. In all cases of carcinoma ex pleomorphic adenoma, a PA "ghost" was identified, and the malignant element was either undifferentiated carcinoma or adenocarcinoma. Results. The results showed negative nuclear expression of P53 in normal parotid gland. Nuclear P53 was expressed strongly in 6/29 (20.7%) pleomorphic salivary adenoma and 10/27 (37%) carcinoma ex pleomorphic adenoma. Conclusion. Our data suggest that inactivation of p53 may play an important role in the evolution of pleomorphic salivary adenoma and carcinoma ex pleomorphic adenoma.
Figures








Similar articles
-
The expression of FHIT in salivary carcinoma ex pleomorphic adenoma.Anticancer Res. 2012 Aug;32(8):3147-52. Anticancer Res. 2012. PMID: 22843886
-
Expression of p21 is dependent on or independent of p53 in carcinoma ex pleomorphic adenoma (undifferentiated and adenocarcinoma types).Pol J Pathol. 2012 Dec;63(4):286-91. doi: 10.5114/pjp.2012.32778. Pol J Pathol. 2012. PMID: 23359201
-
Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas.Arch Pathol Lab Med. 2008 Dec;132(12):1907-11. doi: 10.5858/132.12.1907. Arch Pathol Lab Med. 2008. PMID: 19061288
-
Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.Head Neck Pathol. 2018 Mar;12(1):82-88. doi: 10.1007/s12105-017-0829-7. Epub 2017 Jun 6. Head Neck Pathol. 2018. PMID: 28589437 Free PMC article. Review.
-
Brain metastasis of carcinoma ex pleomorphic adenoma of the parotid gland: case report and review of the literature.Acta Neurochir (Wien). 2017 Mar;159(3):459-463. doi: 10.1007/s00701-017-3080-9. Epub 2017 Jan 20. Acta Neurochir (Wien). 2017. PMID: 28108853 Review.
Cited by
-
GSK3β and CREB3 gene expression profiling in benign and malignant salivary gland tumors.Iran Biomed J. 2012;16(3):140-4. doi: 10.6091/IBJ.1050.2012. Iran Biomed J. 2012. PMID: 23023215 Free PMC article.
-
Immunohistochemical expression of p16 in Carcinoma Ex-pleomorphic Adenoma (undifferentiated and Adenocarcinoma Types).J Clin Diagn Res. 2013 Dec;7(12):3054-6. doi: 10.7860/JCDR/2013/7380.3851. Epub 2013 Dec 15. J Clin Diagn Res. 2013. PMID: 24551726 Free PMC article.
-
Immunohistochemical profiling of Bcl-2 and EGFR proteins in cervical carcinoma at a tertiary hospital in Ghana.Niger Med J. 2025 Jun 16;66(2):575-585. doi: 10.71480/nmj.v66i2.713. eCollection 2025 Mar-Apr. Niger Med J. 2025. PMID: 40703893 Free PMC article.
References
-
- Ungari C, Paparo F, Colangeli W, Iannetti G. Parotid glands tumours: overview of a 10-years experience with 282 patients, focusing on 231 benign epithelial neoplasms. European Review for Medical and Pharmacological Sciences. 2008;12(5):321–325. - PubMed
-
- Demasi APD, Furuse C, Soares AB, Altemani A, Araújo VC. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor α are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation. Human Pathology. 2009;40(3):390–397. - PubMed
-
- Suzuki H, Fujioka Y. Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland. Diagnostic Molecular Pathology. 1998;7(4):224–231. - PubMed
-
- Numata T, Hiruma K, Tsukuda T, Asano T. Malignant mixed tumor. Gan to Kagaku Ryoho. Cancer & Chemotherapy. 2004;31(3):314–317. - PubMed
-
- Yamamoto Y, Kishimoto Y, Wistuba II, et al. DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining. Pathology International. 1998;48(4):265–272. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous